Cross Country Healthcare Acquisition Faces Investor Doubts Amid Regulatory Delays

Cross Country Healthcare finds itself navigating turbulent waters as its proposed acquisition by Aya Healthcare faces mounting skepticism from investors. The stock’s current trading pattern reflects deep market concerns about the deal’s completion, with shares trading at a substantial 42% discount to the proposed cash offer price. This significant gap underscores widespread doubt about the transaction’s ultimate success.

The company’s third quarter 2025 results fell short of market expectations on multiple fronts, compounding the acquisition-related concerns. Both revenue and earnings missed analyst projections, prompting management to take the unusual step of canceling the earnings presentation and withdrawing financial guidance—officially attributed to the pending transaction.

Key financial Read more...